Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Design Example: Maintaining Level of an Embankment01:19

Design Example: Maintaining Level of an Embankment

418
Constructing a roadway embankment over uneven terrain requires precise leveling to ensure stability and proper drainage. Surveyors use a leveling instrument and staff to calculate ground elevations and determine the required fill material at each point along the embankment alignment.The process begins by positioning a leveling instrument near a benchmark with a known elevation. A backsight reading establishes the instrument height, which serves as a reference for subsequent measurements. A...
418
Genomics02:02

Genomics

39.9K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
39.9K
Nuclear Stability03:18

Nuclear Stability

23.0K
Protons and neutrons, collectively called nucleons, are packed together tightly in a nucleus. With a radius of about 10−15 meters, a nucleus is quite small compared to the radius of the entire atom, which is about 10−10 meters. Nuclei are extremely dense compared to bulk matter, averaging 1.8 × 1014 grams per cubic centimeter. If the earth’s density were equal to the average nuclear density, the earth’s radius would be only about 200 meters.
To hold positively charged protons together...
23.0K
RNA Stability01:53

RNA Stability

35.7K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
35.7K
Genome Size and the Evolution of New Genes03:21

Genome Size and the Evolution of New Genes

9.0K
While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
9.0K
Stability01:28

Stability

395
The time response of a linear time-invariant (LTI) system can be divided into transient and steady-state responses. The transient response represents the system's initial reaction to a change in input and diminishes to zero over time. In contrast, the steady-state response is the behavior that persists after the transient effects have faded.
The stability of an LTI system is determined by the roots of its characteristic equation, known as poles. A system is stable if it produces a bounded...
395

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and application of organoid technology in pituitary neuroendocrine tumor research.

The Journal of international medical research·2026
Same author

Biocontrol of Angelica sinensis root rot and degradation of neosolaniol toxin by a novel Trichoderma asperellum M2 strain.

BMC microbiology·2026
Same author

Biocontrol mechanisms of two <i>Paenibacillus</i> strains against <i>Astragalus membranaceus</i> root rot and their effects on soil microecological structure.

Frontiers in microbiology·2026
Same author

The State of the Art in Defect Monitoring Technologies for Selective Laser Melting Processes.

3D printing and additive manufacturing·2026
Same author

Development and validation of a novel analytical method for related substances of resmetirom and identification of new degradation products.

Frontiers in chemistry·2026
Same author

circOMA1 delivered by exosomes regulates DRD2‑mediated prolactinoma resistance.

International journal of molecular medicine·2026

Related Experiment Video

Updated: Jan 24, 2026

Somatic Genome-Engineered Mouse Models Using In Vivo Microinjection and Electroporation
08:06

Somatic Genome-Engineered Mouse Models Using In Vivo Microinjection and Electroporation

Published on: May 5, 2023

2.5K

A model for CDK2 in maintaining genomic stability.

Yonghong Zhu1

  • 1Department of Discovery Research, DNAX Research, Incorporated, Palo Alto, California 94304, USA. Yonghong.zhu@dnax.org

Cell Cycle (Georgetown, Tex.)
|October 20, 2004
PubMed
Summary

Targeting CDK2/cyclin A in cancer cells by inhibiting S phase CDK2 activity can trigger cell death. This approach leverages the cell cycle

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Cycle Regulation

Background:

  • CDK2/cyclin A activity is elevated in human cancer cells.
  • This activity is crucial for the dynamic regulation of MCM proteins during DNA replication.
  • Targeting CDK2/cyclin A presents a potential anti-cancer strategy.

Purpose of the Study:

  • To investigate the effects of S phase CDK2 inhibition on DNA replication and cell fate in cancer cells.
  • To explore the mechanism by which CDK2 inhibition leads to selective cell deletion.

Main Methods:

  • Inhibition of CDK2 activity during the S phase of the cell cycle.
  • Analysis of MCM protein association with DNA.
  • Assessment of DNA double-strand breaks (DSB) and RPA-ssDNA intermediates.

More Related Videos

An Alternative Culture Method to Maintain Genomic Hypomethylation of Mouse Embryonic Stem Cells Using MEK Inhibitor PD0325901 and Vitamin C
11:53

An Alternative Culture Method to Maintain Genomic Hypomethylation of Mouse Embryonic Stem Cells Using MEK Inhibitor PD0325901 and Vitamin C

Published on: June 1, 2018

7.0K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

21.2K

Related Experiment Videos

Last Updated: Jan 24, 2026

Somatic Genome-Engineered Mouse Models Using In Vivo Microinjection and Electroporation
08:06

Somatic Genome-Engineered Mouse Models Using In Vivo Microinjection and Electroporation

Published on: May 5, 2023

2.5K
An Alternative Culture Method to Maintain Genomic Hypomethylation of Mouse Embryonic Stem Cells Using MEK Inhibitor PD0325901 and Vitamin C
11:53

An Alternative Culture Method to Maintain Genomic Hypomethylation of Mouse Embryonic Stem Cells Using MEK Inhibitor PD0325901 and Vitamin C

Published on: June 1, 2018

7.0K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

21.2K
  • Evaluation of ATM, ATR, and p53 pathway activation.
  • Main Results:

    • CDK2 inhibition during replication increases MCM complex association with DNA.
    • This leads to uncontrolled DNA rereplication.
    • Overreplication induces DNA double-strand breaks and RPA-ssDNA intermediates.
    • Activation of ATM and ATR pathways triggers a p53 response.

    Conclusions:

    • S phase CDK2 inhibition causes DNA rereplication and subsequent cell death.
    • The p53-mediated response selectively eliminates cancer cells with unresolved rereplication.
    • Targeting CDK2/cyclin A is a promising strategy for cancer therapy.